Answers are grounded in this paper and cite their sources.
Background Although all Helicobacter pylori (H. pylori)‐positive patients should receive eradication therapy, the therapy is a challenge for patients allergic to penicillin. There have been a few reports on the efficacy of eradication therapy for such patients. Objective To analyze the efficacy of vonoprazan or proton pump inhibitor (PPI)‐based 7‐day triple therapy in patients allergic to penicillin. Materials and Methods A total of 88 consecutive patients allergic to penicillin who received H. pylori eradication therapy were retrospectively analyzed. Thirty‐one patients had a history of failed eradication therapy. Four 7‐day regimens were prescribed during the study period: clarithromycin‐metronidazole‐PPI (13 patients), clarithromycin‐metronidazole‐vonoprazan (14 patients), metronidazole‐sitafloxacin‐PPI (44 patients) and metronidazole‐sitafloxacin‐vonoprazan (17 patients). A 13C‐urea breath test was used for confirmation of eradication, and efficacy of eradication was evaluated by “intention‐to‐treat” analysis and “per‐protocol” analysis. Results Intention‐to‐treat and per‐protocol eradication rates were 46.2%/54.6% for patients who received clarithromycin‐metronidazole‐PPI, 92.9/92.9% for patients who received clarithromycin‐metronidazole‐vonoprazan, 100/100% for patients who received metronidazole‐sitafloxacin‐PPI and 88.2/93.8% for patients who received metronidazole‐sitafloxacin‐vonoprazan. For first eradication, vonoprazan significantly raised the intention‐to‐treat efficacy of the triple therapy including clarithromycin‐metronidazole (vonoprazan: 92.9%, PPI: 46.2%, P=.0128). A 7‐day regimen consisting of metronidazole and sitafloxacin was effective for patients allergic to penicillin with or without past failure of eradication. Conclusion For first eradication in patients allergic to penicillin, a 7‐day triple therapy consisting of clarithromycin, metronidazole and vonoprazan could be a candidate eradication regimen.
No takes yet. Share an insight, caveat, or question.
Ono et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: